Click to Enlarge

Aging: The Longevity Dividend


Book Series:  A Cold Spring Harbor Perspectives in Medicine Collection
Subject Area(s):  Aging ResearchHuman Biology and DiseaseGenetics

Edited by S. Jay Olshansky, University of Illinois at Chicago, School of Public Health; George M. Martin, University of Washington; James L. Kirkland, Mayo Clinic

Download a Free Excerpt from Aging: The Longevity Dividend:

Foreword, Contents, and Preface
Index


© 2016 • 256 pages, illustrated (26 color, 5 B&W), index
Paperback • $79 55.30 (click here to price in UK Pounds)
ISBN  978-1-621821-63-2
You save: 30%
You will receive free shipping on this item at checkout.
Free shipping offer applies to direct website purchases by individual U.S. and Canada customers only.

This title also available in: Hardcover

Print Book + eBook
    Best value!
$154 $71.10 Add To Cart
Print Book$79 $55.30 Add To Cart
eBook$75 $60.00 Add To Cart

Bulk eBook discounts available for your lab or class. Click here to inquire.

eBooks use Adobe Digital Editions software. Click here for more information.

  •     Description    
  •     Contents    
  •     Reviews    
  •     Related Titles    

Description

Aging is one of the greatest challenges currently facing society. People are living longer than ever, but many of the later years are fraught with frailty and disease, placing an enormous burden on health-care systems. Understanding the biological changes that occur during aging and developing strategies to address them are therefore urgently needed.

Written and edited by experts in the field, this collection from Cold Spring Harbor Perspectives in Medicine examines the biological basis of aging, strategies that may extend health span, and the societal implications of delayed aging. Contributors discuss genetic variants that accelerate or protect against aging, biochemical pathways that modulate longevity (e.g., mTOR), biological consequences of aging (e.g., decline in stem cell function), and various animal models used to study aging processes. They emphasize that age-delaying interventions will yield greater health and vitality than disease-specific treatments. Drugs that may promote health span or longevity (e.g., metformin) and efforts to prevent and treat frailty (e.g., through exercise) are explored.

The authors consider the socioeconomic benefits and costs of delayed aging and also outline directions for future research and translational efforts. This volume will serve as a vital reference for all involved in the fields of geroscience and geriatric medicine, as well as anyone wishing to understand physiological processes that generate health and disease, regardless of chronological age.

Contents

Foreword
Janko Nikolich-Žugich
Preface
INTRODUCTION
The Emergence of Geroscience as an Interdisciplinary Approach to the Enhancement of Health Span and Life Span
Felipe Sierra
PART I: BASIC MECHANISMS OF BIOLOGICAL AGING
The Role of the Microenvironmental Niche in Declining Stem-Cell Functions Associated with Biological Aging
Nathan A. DeCarolis, Elizabeth D. Kirby, Tony Wyss-Coray, and Theo D. Palmer
Biochemical Genetic Pathways that Modulate Aging in Multiple Species
Alessandro Bitto, Adrienne M. Wang, Christopher F. Bennett, and Matt Kaeberlein
DNA Damage, DNA Repair, Aging, and Neurodegeneration
Scott Maynard, Evandro Fei Fang, Morten Scheibye-Knudsen, Deborah L. Croteau, and Vilhelm A. Bohr
How Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend Initiative
Fuki M. Hisama, Junko Oshima, and George M. Martin
Dissecting the Mechanisms Underlying Successful Human Health Span and Life Span
Sofiya Milman and Nir Barzilai
The Companion Dog as a Model for the Longevity Dividend
Kate E. Creevy, Steven N. Austad, Jessica M. Hoffman, Dan G. O’Neill, and Daniel E.L. Promislow
PART II: CLINICAL AND TRANSLATIONAL ASPECTS OF AGING
Translating the Science of Aging into Therapeutic Interventions
James L. Kirkland
Interventions for Human Frailty: Physical Activity as a Model
Linda P. Fried
The Aging Heart
Ying Ann Chiao and Peter S. Rabinovitch
Inhibition of the Mechanistic Target of Rapamycin (mTOR)—Rapamycin and Beyond
Dudley W. Lamming
Metformin: A Hopeful Promise in the Aging Research
Marta G. Novelle, Ahmed Ali, Carlos Diéguez, Michel Bernier, and Rafael de Cabo
PART III: SOCIETAL IMPLICATIONS OF DELAYED AGING
Articulating the Case for the Longevity Dividend
S. Jay Olshansky
The Economic Promise of Delayed Aging
Dana Goldman
Past, Present, and Future of Healthy Life Expectancy
Hiram Beltrán-Sánchez, Samir Soneji, and Eileen M. Crimmins
Has the Rate of Human Aging Already Been Modified?
S. Jay Olshansky
Index

Reviews

review:  “Aging...explores the potential to extend human health by drawing on discoveries about the biology of ageing...the message is clear: it is time to begin the revolution in medical approaches to ageing-related disease and late-life health.”
      —Nature